Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Screening for down syndrome using trophoblast retrieval and isolation of the cervix: preliminary study

  • Lee, Min Jin (Department of Obstetrics and Gynecology, CHA Ilsan Medical Center, CHA University) ;
  • Kim, Soo Hyun (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Park, Hee Jin (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Shim, Sung Han (Genetics Laboratory, Fertility Center of CHA Gangnam Medical Center, CHA University) ;
  • Jang, Hee Yeon (Genetics Laboratory, Fertility Center of CHA Gangnam Medical Center, CHA University) ;
  • Cha, Dong Hyun (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University)
  • Received : 2020.05.24
  • Accepted : 2020.08.08
  • Published : 2020.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Trisomy 21, the cause of Down syndrome (DS) with various medical problems, is the most common aneuploidy during the fetal period. For diagnosis, a non-invasive screening test using maternal blood, which cannot be confirmed and invasive confirmation test with a risk of miscarriage, may be performed. The trophoblast retrieval and isolation of the cervix (TRIC) have been proposed by some researchers as an alternative to overcome the limitations of current tests. We experimented using TRIC to identify the possibility of trisomy 21 for the first time in Asia. Materials and Methods: Three cases of DS were analyzed confirmed by invasive tests (chorionic villus sampling, amniocentesis). All samples of trophoblasts immediately were immersed in phosphate-buffered saline and processed with formalin for fixation. The trophoblasts were isolated using an anti-human leukocyte antigen-G antibody coupled to magnetic nanoparticles. β-human chorionic gonadotropin (hCG)-expressing cells were considered as trophoblast cells, and the detection rate calculated. DS was confirmed by fluorescence in situ hybridization (FISH). Results: The mean trophoblast detection rate using β-hCG was 78.1%, and the detection rate using FISH was 22.2%. In all cases, the trisomy of chromosome 21 was identified. Conclusion: Trophoblast can be obtained from the five weeks of gestation and has a high detection rate, so it is noted that it can replace the current prenatal genetic test. To realize the clinical application as a prenatal genetic test, we will need additional efforts to identify trisomy 21 as well as other chromosomal abnormalities in future large-scale studies.

Keywords

References

  1. Wellesley D, Dolk H, Boyd PA, Greenlees R, Haeusler M, Nelen V, et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. Eur J Hum Genet 2012;20:521-6. https://doi.org/10.1038/ejhg.2011.246
  2. Bull MJ; Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2011;128:393-406. https://doi.org/10.1542/peds.2011-1605
  3. Scharrer S, Stengel-Rutkowski S, Rodewald-Rudescu A, Erdlen E, Zang KD. Reproduction in a female patient with Down's syndrome. Case report of a 46, XY child showing slight phenotypical anomalies, born to a 47, XX, + 21 mother. Humangenetik 1975;26:207-14. https://doi.org/10.1007/BF00281455
  4. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers 2020;6:9. https://doi.org/10.1038/s41572-019-0143-7
  5. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Practice bulletin no. 162: prenatal diagnostic testing for genetic disorders. Obstet Gynecol 2016;127:e108-22. https://doi.org/10.1097/AOG.0000000000001405
  6. Dashe JS. Aneuploidy screening in pregnancy. Obstet Gynecol 2016;128:181-94. https://doi.org/10.1097/AOG.0000000000001385
  7. Lee MJ, Kim SH, Shim SH, Jang HY, Park HJ, Cha DH. Optimization protocol of fixation method for trophoblast retrieval from the cervix (TRIC): a preliminary study. Diagnostics (Basel) 2020;10:300. https://doi.org/10.3390/diagnostics10050300
  8. Loane M, Morris JK, Addor MC, Arriola L, Budd J, Doray B, et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 2013;21:27-33. https://doi.org/10.1038/ejhg.2012.94
  9. Shin M, Besser LM, Kucik JE, Lu C, Siffel C, Correa A; Congenital Anomaly Multistate Prevalence and Survival Collaborative. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics 2009;124:1565-71. https://doi.org/10.1542/peds.2009-0745
  10. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7. https://doi.org/10.1016/S0140-6736(97)02174-0
  11. Committee opinion no. 640: cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015;126:e31-7. https://doi.org/10.1097/01.AOG.0000471172.63927.b6
  12. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013;41:26-32. https://doi.org/10.1002/uog.12331
  13. Shettles LB. Use of the Y chromosome in prenatal sex determination. Nature 1971;230:52-3. https://doi.org/10.1038/230052b0
  14. Moser G, Drewlo S, Huppertz B, Armant DR. Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. Hum Reprod Update 2018;24:484-96. https://doi.org/10.1093/humupd/dmy008
  15. Fritz R, Kohan-Ghadr HR, Sacher A, Bolnick AD, Kilburn BA, Bolnick JM, et al. Trophoblast retrieval and isolation from the cervix (TRIC) is unaffected by early gestational age or maternal obesity. Prenat Diagn 2015;35:1218-22. https://doi.org/10.1002/pd.4681
  16. Branum AM, Ahrens KA. Trends in timing of pregnancy awareness among US women. Matern Child Health J 2017;21:715-26. https://doi.org/10.1007/s10995-016-2155-1
  17. Orr JW Jr, Barrett JM, Orr PF, Holloway RW, Holimon JL. The efficacy and safety of the cytobrush during pregnancy. Gynecol Oncol 1992;44:260-2. https://doi.org/10.1016/0090-8258(92)90053-L
  18. Kadam L, Jain C, Kohan-Ghadr HR, Krawetz SA, Drewlo S, Armant DR. Endocervical trophoblast for interrogating the fetal genome and assessing pregnancy health at five weeks. Eur J Med Genet 2019;62:103690. https://doi.org/10.1016/j.ejmg.2019.103690
  19. Jain CV, Kadam L, van Dijk M, Kohan-Ghadr HR, Kilburn BA, Hartman C, et al. Fetal genome profiling at 5 weeks of gestation after noninvasive isolation of trophoblast cells from the endocervical canal. Sci Transl Med 2016;8:363re4. https://doi.org/10.1126/scitranslmed.aah4661